Skip to main content
. 2020 Mar 5;11:1200. doi: 10.1038/s41467-020-15089-z

Fig. 1.

Fig. 1

The same genetic lesions targeted to OSE and FTE organoids result in different HGSOC-subtype in mice and different sensitivities to standard of care chemotherapy in vitro.